We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bristol Myers Squibb Co | NYSE:BMY | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
-0.16 | -0.36% | 44.55 | 45.17 | 44.4828 | 45.00 | 14,179,384 | 00:58:50 |
Two members of Bristol-Myers Squibb Co.'s (BMY) management council are leaving the drug maker effective April 1, and their responsibilities will be transferred to another executive.
The moves suggest that incoming chief executive Lamberto Andreotti is putting his own stamp on the New York company's management team. Andreotti, Bristol's chief operating officer, was named earlier this month to succeed James Cornelius as CEO, effective May 4. Cornelius will remain chairman.
The departing executives are Robert Zito, senior vice president of corporate and business communications and chief communications officer, and Anthony McBride, senior vice president of human resources, Bristol-Myers spokeswoman Tracy Furey said Wednesday.
The organizations they oversee will report to John Celentano, president of emerging markets and Asia Pacific.
Furey declined to comment on the reasons for the changes.
Zito joined Bristol-Myers in 2004 after serving as the head of public relations at the New York Stock Exchange. "I had a wonderful six years," he said Wednesday, but declined to elaborate on his departure.
McBride was named head of HR in 2008; he joined Bristol in 1995. He couldn't be reached for comment.
Bristol shares declined 6 cents to $26.73 Wednesday.
-By Peter Loftus, Dow Jones Newswires; 215-656-8289; peter.loftus@dowjones.com
1 Year Bristol Myers Squibb Chart |
1 Month Bristol Myers Squibb Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions